Global and Japan Opioids Market 2020 by Manufacturers, Type and Application, Forecast to 2025

$3480

Market Overview

The global Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 16810 million by 2025, from USD 15260 million in 2019.

The Opioids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Opioids market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Opioids market has been segmented into Immediate-Release/Short-Acting Opioid, Extended-Release/Long-Acting Opioid, etc.

Breakdown by Application, Opioids has been segmented into Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Opioids Market Share Analysis

Opioids competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Opioids sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids sales, revenue and market share for each player covered in this report.

The major players covered in Opioids are: Purdue Pharma L.P., Pfizer, Inc., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Limited., Allergan, Egalet Corporation, Janssen Pharmaceuticals, Inc., etc. Among other players domestic and global, Opioids market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Opioids market are listed below:

Purdue Pharma L.P.

Pfizer, Inc.

West-Ward Pharmaceuticals Corporation

Sun Pharmaceutical Industries Limited.

Allergan

Egalet Corporation

Janssen Pharmaceuticals, Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Immediate-Release/Short-Acting Opioid

Extended-Release/Long-Acting Opioid

Market segment by Application, can be divided into

Pain Relief

Anesthesia

Cough Suppression

Diarrhea Suppression

Deaddiction

Table of Contents

1 Market Overview

1.1 Opioids Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Opioids Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Immediate-Release/Short-Acting Opioid

1.2.3 Extended-Release/Long-Acting Opioid

1.3 Market Analysis by Application

1.3.1 Overview: Global Opioids Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Pain Relief

1.3.3 Anesthesia

1.3.4 Cough Suppression

1.3.5 Diarrhea Suppression

1.3.6 Deaddiction

1.4 Global Opioids Market Size and Forecast (2015-2025)

1.4.1 Global Opioids Revenue and Forecast (2015-2025)

1.4.2 Global Opioids Sales and Forecast (2015-2025)

1.5 Global Opioids Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 Purdue Pharma L.P.

2.1.1 Purdue Pharma L.P. Details

2.1.2 Purdue Pharma L.P. Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Purdue Pharma L.P. SWOT Analysis

2.1.4 Purdue Pharma L.P. Product and Services

2.1.5 Purdue Pharma L.P. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Pfizer, Inc.

2.2.1 Pfizer, Inc. Details

2.2.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Pfizer, Inc. SWOT Analysis

2.2.4 Pfizer, Inc. Product and Services

2.2.5 Pfizer, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 West-Ward Pharmaceuticals Corporation

2.3.1 West-Ward Pharmaceuticals Corporation Details

2.3.2 West-Ward Pharmaceuticals Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 West-Ward Pharmaceuticals Corporation SWOT Analysis

2.3.4 West-Ward Pharmaceuticals Corporation Product and Services

2.3.5 West-Ward Pharmaceuticals Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Sun Pharmaceutical Industries Limited.

2.4.1 Sun Pharmaceutical Industries Limited. Details

2.4.2 Sun Pharmaceutical Industries Limited. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Sun Pharmaceutical Industries Limited. SWOT Analysis

2.4.4 Sun Pharmaceutical Industries Limited. Product and Services

2.4.5 Sun Pharmaceutical Industries Limited. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Allergan

2.5.1 Allergan Details

2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Allergan SWOT Analysis

2.5.4 Allergan Product and Services

2.5.5 Allergan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Egalet Corporation

2.6.1 Egalet Corporation Details

2.6.2 Egalet Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Egalet Corporation SWOT Analysis

2.6.4 Egalet Corporation Product and Services

2.6.5 Egalet Corporation Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Janssen Pharmaceuticals, Inc.

2.7.1 Janssen Pharmaceuticals, Inc. Details

2.7.2 Janssen Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Janssen Pharmaceuticals, Inc. SWOT Analysis

2.7.4 Janssen Pharmaceuticals, Inc. Product and Services

2.7.5 Janssen Pharmaceuticals, Inc. Opioids Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Opioids Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Opioids Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Opioids Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: Japan

3.2.1 Key Players Opioids Sales in Japan (2018-2019)

3.2.2 Japan Opioids Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Opioids Manufacturer Market Share in 2019

3.3.2 Top 6 Opioids Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Opioids Market Size by Geography (2015-2020)

4.1.1 Global Opioids Sales by Geography (2015-2020)

4.1.2 Global Opioids Revenue by Regions (2015-2020)

4.2 Global Opioids Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Opioids Sales and Forecast by Regions (2020-2025)

4.2.2 Global Opioids Revenue and Forecast by Regions (2020-2025)

4.3 North America Opioids Market Size and Forecast (2015-2025)

4.4 Europe Opioids Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Opioids Market Size and Forecast (2015-2025)

4.6 South America Opioids Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Opioids Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Opioids Market Size by Country (2015-2020)

5.1.1 North America Opioids Sales and Market Share by Country (2015-2020)

5.1.2 North America Opioids Revenue and Market Share by Country (2015-2020)

5.2 North America Opioids Market Size and Forecast by Country (2020-2025)

5.2.1 North America Opioids Sales and Forecast by Country (2020-2025)

5.2.2 North America Opioids Revenue and Forecast by Country (2020-2025)

5.3 United States Opioids Market Size and Forecast (2015-2025)

5.4 Canada Opioids Market Size and Forecast (2015-2025)

5.5 Mexico Opioids Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Opioids Market Size by Country (2015-2020)

6.1.1 Europe Opioids Sales by Country (2015-2020)

6.1.2 Europe Opioids Revenue by Country (2015-2020)

6.2 Europe Opioids Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Opioids Sales and Forecast by Country (2020-2025)

6.2.2 Europe Opioids Revenue and Forecast by Country (2020-2025)

6.3 Germany Opioids Market Size and Forecast (2015-2025)

6.4 United Kingdom Opioids Market Size and Forecast (2015-2025)

6.5 France Opioids Market Size and Forecast (2015-2025)

6.6 Russia Opioids Market Size and Forecast (2015-2025)

6.7 Italy Opioids Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Opioids Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Opioids Sales by Region (2015-2020)

7.1.2 Asia-Pacific Opioids Revenue by Region (2015-2020)

7.2 Asia-Pacific Opioids Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Opioids Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Opioids Revenue and Forecast by Region (2020-2025)

7.3 China Opioids Market Size and Forecast (2015-2025)

7.4 Japan Opioids Market Size and Forecast (2015-2025)

7.5 Korea Opioids Market Size and Forecast (2015-2025)

7.6 India Opioids Market Size and Forecast (2015-2025)

7.7 Southeast Asia Opioids Market Size and Forecast (2015-2025)

7.8 Australia Opioids Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Opioids Market Size by Country (2015-2020)

8.1.1 South America Opioids Sales by Country (2015-2020)

8.1.2 South America Opioids Revenue by Country (2015-2020)

8.2 South America Opioids Market Size and Forecast by Country (2020-2025)

8.2.1 South America Opioids Sales and Forecast by Country (2020-2025)

8.2.2 South America Opioids Revenue and Forecast by Country (2020-2025)

8.3 Brazil Opioids Market Size and Forecast (2015-2025)

8.4 Argentina Opioids Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Opioids Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Opioids Sales by Country (2015-2020)

9.1.2 Middle East & Africa Opioids Revenue by Country (2015-2020)

9.2 Middle East & Africa Opioids Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Opioids Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Opioids Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Opioids Market Size and Forecast (2015-2025)

9.4 Turkey Opioids Market Size and Forecast (2015-2025)

9.5 Egypt Opioids Market Size and Forecast (2015-2025)

9.6 South Africa Opioids Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Opioids Market Size by Type (2015-2020)

10.1.1 Global Opioids Sales by Type (2015-2020)

10.1.2 Global Opioids Revenue by Type (2015-2020)

10.1.3 Global Opioids Price by Type (2015-2020)

10.2 Global Opioids Market Size and Forecast by Type (2020-2025)

10.2.1 Global Opioids Sales and Forecast by Type (2020-2025)

10.2.2 Global Opioids Revenue and Forecast by Type (2020-2025)

10.2.3 Global Opioids Price and Forecast by Type (2020-2025)

10.3 Japan Opioids Market Size and Forecast by Type (2015-2025)

10.3.1 Japan Opioids Market Size by Type (2015-2020)

10.3.2 Japan Opioids Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Opioids Market Size by Application (2015-2020)

11.1.1 Global Opioids Sales by Application (2015-2020)

11.1.2 Global Opioids Revenue by Application (2015-2020)

11.1.3 Global Opioids Price by Application (2015-2020)

11.2 Global Opioids Market Size and Forecast by Application (2020-2025)

11.2.1 Global Opioids Sales and Forecast by Application (2020-2025)

11.2.2 Global Opioids Revenue and Forecast by Application (2020-2025)

11.2.3 Global Opioids Price and Forecast by Application (2020-2025)

11.3 Japan Opioids Market Size and Forecast by Application (2015-2025)

11.3.1 Japan Opioids Market Size by Application (2015-2020)

11.3.2 Japan Opioids Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US


List of Tables

Table 1. Global Opioids Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Opioids by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Opioids Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Opioids Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors

Table 6. Purdue Pharma L.P. Opioids Major Business

Table 7. Purdue Pharma L.P. Opioids Total Revenue (USD Million) (2018-2019)

Table 8. Purdue Pharma L.P. SWOT Analysis

Table 9. Purdue Pharma L.P. Opioids Product and Services

Table 10. Purdue Pharma L.P. Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 11. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors

Table 12. Pfizer, Inc. Opioids Major Business

Table 13. Pfizer, Inc. Opioids Total Revenue (USD Million) (2018-2019)

Table 14. Pfizer, Inc. SWOT Analysis

Table 15. Pfizer, Inc. Opioids Product and Services

Table 16. Pfizer, Inc. Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 17. West-Ward Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors

Table 18. West-Ward Pharmaceuticals Corporation Opioids Major Business

Table 19. West-Ward Pharmaceuticals Corporation Opioids Total Revenue (USD Million) (2018-2019)

Table 20. West-Ward Pharmaceuticals Corporation SWOT Analysis

Table 21. West-Ward Pharmaceuticals Corporation Opioids Product and Services

Table 22. West-Ward Pharmaceuticals Corporation Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 23. Sun Pharmaceutical Industries Limited. Basic Information, Manufacturing Base and Competitors

Table 24. Sun Pharmaceutical Industries Limited. Opioids Major Business

Table 25. Sun Pharmaceutical Industries Limited. Opioids Total Revenue (USD Million) (2018-2019)

Table 26. Sun Pharmaceutical Industries Limited. SWOT Analysis

Table 27. Sun Pharmaceutical Industries Limited. Opioids Product and Services

Table 28. Sun Pharmaceutical Industries Limited. Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 29. Allergan Basic Information, Manufacturing Base and Competitors

Table 30. Allergan Opioids Major Business

Table 31. Allergan Opioids Total Revenue (USD Million) (2018-2019)

Table 32. Allergan SWOT Analysis

Table 33. Allergan Opioids Product and Services

Table 34. Allergan Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 35. Egalet Corporation Basic Information, Manufacturing Base and Competitors

Table 36. Egalet Corporation Opioids Major Business

Table 37. Egalet Corporation Opioids Total Revenue (USD Million) (2018-2019)

Table 38. Egalet Corporation SWOT Analysis

Table 39. Egalet Corporation Opioids Product and Services

Table 40. Egalet Corporation Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 41. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 42. Janssen Pharmaceuticals, Inc. Opioids Major Business

Table 43. Janssen Pharmaceuticals, Inc. Opioids Total Revenue (USD Million) (2018-2019)

Table 44. Janssen Pharmaceuticals, Inc. SWOT Analysis

Table 45. Janssen Pharmaceuticals, Inc. Opioids Product and Services

Table 46. Janssen Pharmaceuticals, Inc. Opioids Sales (MT), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)

Table 47. Global Opioids Sales by Manufacturer (2018-2019) (MT)

Table 48. Global Opioids Revenue by Manufacturer (2018-2019) (USD Million)

Table 49. Key Players Opioids Sales in Japan (2018-2019) (MT)

Table 50. Key Players Opioids Sales Market Share in Japan (2018-2019)

Table 51. Key Players Revenue of Opioids in Japan (2018-2019) (USD Million)

Table 52. Global Opioids Sales by Regions (2015-2020) (MT)

Table 53. Global Opioids Sales Market Share by Regions (2015-2020)

Table 54. Global Opioids Revenue by Regions (2015-2020) (USD Million)

Table 55. Global Opioids Sales and Forecast by Regions (2020-2025) (MT)

Table 56. Global Opioids Sales Market Share by Regions (2020-2025)

Table 57. Global Opioids Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 58. Global Opioids Revenue Market Share by Regions (2020-2025) (USD Million)

Table 59. North America Opioids Sales by Countries (2015-2020) (MT)

Table 60. North America Opioids Sales Market Share by Countries (2015-2020)

Table 61. North America Opioids Revenue by Countries (2015-2020) (USD Million)

Table 62. North America Opioids Revenue Market Share by Countries (2015-2020)

Table 63. North America Opioids Sales by Country (2020-2025) (MT)

Table 64. North America Opioids Sales Market Share by Country (2020-2025)

Table 65. North America Opioids Revenue by Country (2020-2025) (USD Million)

Table 66. North America Opioids Revenue Market Share by Country (2020-2025)

Table 67. Europe Opioids Sales by Countries (2015-2020) (MT)

Table 68. Europe Opioids Sales Market Share by Countries (2015-2020)

Table 69. Europe Opioids Revenue by Countries (2015-2020) (USD Million)

Table 70. Europe Opioids Revenue Market Share by Countries (2015-2020)

Table 71. Europe Opioids Sales by Country (2020-2025) (MT)

Table 72. Europe Opioids Sales Market Share by Country (2020-2025)

Table 73. Europe Opioids Revenue by Country (2020-2025) (USD Million)

Table 74. Europe Opioids Revenue Market Share by Country (2020-2025)

Table 75. Asia-Pacific Opioids Sales by Countries (2015-2020) (MT)

Table 76. Asia-Pacific Opioids Sales Market Share by Countries (2015-2020)

Table 77. Asia-Pacific Opioids Revenue by Countries (2015-2020) (USD Million)

Table 78. Asia-Pacific Opioids Revenue Market Share by Countries (2015-2020)

Table 79. Asia-Pacific Opioids Sales by Country (2020-2025) (MT)

Table 80. Asia-Pacific Opioids Sales Market Share by Country (2020-2025)

Table 81. Asia-Pacific Opioids Revenue by Country (2020-2025) (USD Million)

Table 82. Asia-Pacific Opioids Revenue Market Share by Country (2020-2025)

Table 83. South America Opioids Sales by Countries (2015-2020) (MT)

Table 84. South America Opioids Sales Market Share by Countries (2015-2020)

Table 85. South America Opioids Revenue by Countries (2015-2020) (USD Million)

Table 86. South America Opioids Revenue Market Share by Countries (2015-2020)

Table 87. South America Opioids Sales by Country (2020-2025) (MT)

Table 88. South America Opioids Sales Market Share by Country (2020-2025)

Table 89. South America Opioids Revenue by Country (2020-2025) (USD Million)

Table 90. South America Opioids Revenue Market Share by Country (2020-2025)

Table 91. Middle East & Africa Opioids Sales by Countries (2015-2020) (MT)

Table 92. Middle East & Africa Opioids Sales Market Share by Countries (2015-2020)

Table 93. Middle East & Africa Opioids Revenue by Countries (2015-2020) (USD Million)

Table 94. Middle East & Africa Opioids Revenue Market Share by Countries (2015-2020)

Table 95. Middle East & Africa Opioids Sales by Country (2020-2025) (MT)

Table 96. Middle East & Africa Opioids Sales Market Share by Country (2020-2025)

Table 97. Middle East & Africa Opioids Revenue by Country (2020-2025) (USD Million)

Table 98. Middle East & Africa Opioids Revenue Market Share by Country (2020-2025)

Table 99. Japan Opioids Sales by Type (2015-2020) (MT)

Table 100. Japan Opioids Sales Market Share by Type (2015-2020)

Table 101. Japan Opioids Revenue by Type (2015-2020) (USD Million)

Table 102. Japan Opioids Revenue Market Share by Type (2015-2020)

Table 103. Japan Opioids Sales by Type (2020-2025) (MT)

Table 104. Japan Opioids Sales Market Share by Type (2020-2025)

Table 105. Japan Opioids Revenue by Type (2020-2025) (USD Million)

Table 106. Japan Opioids Revenue Market Share by Type (2020-2025)

Table 107. Global Opioids Sales by Application (2015-2020) (MT)

Table 108. Global Opioids Sales Market Share by Application (2015-2020)

Table 109. Global Opioids Revenue by Application (2015-2020) (USD Million)

Table 110. Global Opioids Revenue Market Share by Application (2015-2020)

Table 111. Global Opioids Price by Application (2015-2020) (USD/Kg)

Table 112. Global Opioids Sales by Application (2020-2025) (MT)

Table 113. Global Opioids Sales Market Share by Application (2020-2025)

Table 114. Global Opioids Revenue by Application (2020-2025) (USD Million)

Table 115. Global Opioids Revenue Market Share by Application (2020-2025)

Table 116. Global Opioids Price by Application (2020-2025) (USD/Kg)

Table 117. Japan Opioids Sales by Application (2015-2020) (MT)

Table 118. Japan Opioids Sales Market Share by Application (2015-2020)

Table 119. Japan Opioids Revenue by Application (2015-2020) (USD Million)

Table 120. Japan Opioids Revenue Market Share by Application (2015-2020)

Table 121. Japan Opioids Sales by Application (2020-2025) (MT)

Table 122. Japan Opioids Sales Market Share by Application (2020-2025)

Table 123. Japan Opioids Revenue by Application (2020-2025) (USD Million)

Table 124. Japan Opioids Revenue Market Share by Application (2020-2025)

Table 125. Direct Channel Pros & Cons

Table 126. Indirect Channel Pros & Cons

Table 127. Distributors/Traders/ Dealers List

Table 128. Customers of Opioids

Table 129. Market Opportunities in Next Few Years

Table 130. Market Risks Analysis

Table 131. Market Drivers

List of Figures

Figure 1. Opioids Picture

Figure 2. Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Immediate-Release/Short-Acting Opioid Picture

Figure 4. Extended-Release/Long-Acting Opioid Picture

Figure 5. Opioids Sales Market Share by Application in 2019

Figure 6. Pain Relief Picture

Figure 7. Anesthesia Picture

Figure 8. Cough Suppression Picture

Figure 9. Diarrhea Suppression Picture

Figure 10. Deaddiction Picture

Figure 11. Global Opioids Market Status and Outlook (2015-2025) (USD Million)

Figure 12. Global Opioids Sales Growth Rate (2015-2025) (MT)

Figure 13. Global Opioids Sales Market Share by Manufacturer in 2019

Figure 14. Global Opioids Revenue Market Share by Manufacturer in 2019

Figure 15. Key Players Opioids Revenue Market Share in Japan in 2019

Figure 16. Global Top 5 Opioids Manufacturer Market Share in 2019

Figure 17. Top 3 Opioids Players Market Share in Japan in 2019

Figure 18. Global Opioids Revenue Market Share by Regions in 2019

Figure 19. North America Opioids Sales YoY Growth (2015-2025) (MT)

Figure 20. North America Opioids Revenue YoY Growth (2015-2025) (USD Million)

Figure 21. Europe Opioids Sales YoY Growth (2015-2020) (MT)

Figure 22. Europe Opioids Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. Asia-Pacific Opioids Sales YoY Growth (2015-2020) (MT)

Figure 24. Asia-Pacific Opioids Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. South America Opioids Sales YoY Growth (2015-2020) (MT)

Figure 26. South America Opioids Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. Middle East & Africa Opioids Sales YoY Growth (2015-2020) (MT)

Figure 28. Middle East & Africa Opioids Revenue YoY Growth (2015-2020) (USD Million)

Figure 29. North America Opioids Sales Market Share by Country in 2019

Figure 30. North America Opioids Revenue Market Share by Country in 2019

Figure 31. United States Opioids Market Size and Growth Rate (2015-2025) (USD Million)

Figure 32. Canada Opioids Market Size and Growth Rate (2015-2025) (USD Million)

Figure 33. Mexico Opioids Market Size and Growth Rate (2015-2020) (USD Million)

Figure 34. Europe Opioids Revenue Market Share by Country in 2019

Figure 35. Germany Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. United Kingdom Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. France Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Russia Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 39. Italy Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 40. Asia-Pacific Opioids Sales Market Share by Region 2018

Figure 41. Asia-Pacific Opioids Revenue Market Share by Region 2018

Figure 42. China Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. Japan Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Korea Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. India Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. Southeast Asia Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 47. Australia Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 48. South America Opioids Sales Market Share by Country in 2019

Figure 49. South America Opioids Revenue Market Share by Country in 2019

Figure 50. Brazil Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Argentina Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Saudi Arabia Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. Turkey Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Egypt Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 55. South Africa Opioids Market Size Growth Rate (2015-2025) (USD Million)

Figure 56. Global Revenue Market Share of Opioids by Type in 2019

Figure 57. Global Revenue Market Share of Opioids by Application in 2019

Figure 58. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.